NSAIDs Market Recent Trends, In-Depth Analysis, Size And Forecast To 2028

According to Precision Business Insights (PBI) latest report The Global NSAIDs market is expected to be worth USD XX million in 2022, growing at a XX% CAGR from 2022 to 2028. Global NSAIDs Market segmented into following types: By Molecule Type (Ibuprofen, Aspirin, Paracetamol, Diclofenac and Others), By Formulation (Tablets, Capsules, Suspension, Topical Preparations and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) Forecast to 2028. Key player's profiles in the NSAIDs market report are Pfizer Inc., GlaxoSmithKline plc, Boehringer Ingelheim International Gmb, Johnson & Johnson Services, Inc., Bayer AG, AstraZeneca, Zyla Life Sciences and Horizon Therapeutics plc.

Ibuprofen Dominate the NSAIDs Market:
Based on molecule type, Ibuprofen accounted XX% market share and it is expected to grow with a CAGR XX% from 2022-2028. Ibuprofen is a medicine that belongs to the anti-inflammatory drug class. It aids in the reduction of hormones that produce pain and inflammation in the body. Ibuprofen is used to treat fever, toothaches, back pain, headaches, and discomfort, among other things. The medication is a propionic acid derivative that is non-steroidal. Ibuprofen market expansion is aided by an aging population that is more susceptible to diseases and health issues. A rise in patients with cardiovascular diseases, cancer, arthritis, and other chronic conditions can also be considered as favourable impact rendering elements for the industry's growth.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/nsaids-market/

North America leads NSAIDs Market:
North America held significant market share in the NSAIDs market during the forecast period and it is expected to continue the growth in the coming years. Over the next several years, the market is expected to rise due to rising painkiller demand and a growing senior population in North America. For instance, in February 2020, Voltaren Arthritic Pain has been approved by the FDA for the brief treatment of arthritis pain.

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
NSAIDs market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, November 2017, Pfizer announced Celebrex will be reimbursed by insurance for all persons with rheumatoid arthritis, osteoarthritis, or ankylosing spondylitis. Prior to this, insurance benefits were only available to those over the age of 60.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=55093

Detailed Segmentation:
Based on the Molecule Type, the market is segmented into the following:
• Ibuprofen
• Aspirin
• Paracetamol
• Diclofenac
• Others

Based on the formulation, the market is segmented into the following:
• Tablets
• Capsules
• Suspension
• Topical Preparations
• Others

Based on Geography, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.